[Clinical tests on the use of ethoxzolamide in glaucoma therapy (author's transl)].

Abstract

Ethoxzolamide is a potent carboxyanhydrase inhibitor, and its use in chronic glaucoma and in the acute glaucoma attack is described in the present investigation. Ethoxzolamide shows itself to be extremely well tolerated. The frequency and intensity of the side-effects is low. The electrolyte balance remains also after prolonged administration compensated. The important advantage of this drug is its low dosability. Ethoxzolamide, which was already 1958 clinically evaluated (Gordon-Posner), represents a valuable medication for conservative glaucoma therapy.

• Authors: L Mewe
• Journal: Klinische Monatsblatter fur Augenheilkunde (Klin Monbl Augenheilkd) Vol. 173 Issue 3 Pg. 374-8 (Sep 1978) ISSN: 0023-2165 [Print] Germany
• Vernacular Title: Klinische Untersuchungen zur Anwendung von Ethoxzolamid in der Glaukomtherapie.
• PMID: 750712 (Publication Type: English Abstract, Journal Article)

Chemical References

• Thiazoles
• Ethoxzolamide

Topics

• Drug Evaluation
• Ethoxzolamide (administration & dosage, adverse effects, therapeutic use)
• Glaucoma (drug therapy)
• Humans
• Thiazoles (therapeutic use)